8.94
3.59%
+0.31
Handel nachbörslich:
8.94
89bio Inc Aktie (ETNB) Neueste Nachrichten
Taking a Closer Look At 89bio Inc (ETNB) Following Its Recent Trade – Knox Daily - Knox Daily
Knox Daily
Where are the Opportunities in (ETNB) - Stock Traders Daily
Stock Traders Daily
HC Wainwright Reiterates Buy Rating for 89bio (NASDAQ:ETNB) - Defense World
Defense World
Eyenovia (NASDAQ:EYEN) vs. 89bio (NASDAQ:ETNB) Head-To-Head Contrast - Defense World
Defense World
89bio (NASDAQ:ETNB) Stock Rating Reaffirmed by Cantor Fitzgerald - Defense World
Defense World
89bio (NASDAQ:ETNB) Stock Rating Reaffirmed by Cantor Fitzgerald - MarketBeat
MarketBeat
89bio (NASDAQ:ETNB) PT Lowered to $33.00 at Evercore ISI - Defense World
Defense World
New York State Common Retirement Fund Boosts Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Defense World
Insider Selling: PALEKAR ROHAN, 89bio Inc [ETNB] Chief Executive Officer divested 52718 shares – Knox Daily - Knox Daily
Knox Daily
89bio (NASDAQ:ETNB) Receives Buy Rating from HC Wainwright - MarketBeat
MarketBeat
Cantor Fitzgerald Comments on 89bio, Inc.'s FY2024 Earnings (NASDAQ:ETNB) - Defense World
Defense World
89bio (NASDAQ:ETNB) Trading Up 5.5% - MarketBeat
MarketBeat
89bio, Inc. (NASDAQ:ETNB) to Post FY2024 Earnings of ($2.30) Per Share, Cantor Fitzgerald Forecasts - MarketBeat
MarketBeat
89bio (NASDAQ:ETNB) Price Target Cut to $33.00 by Analysts at Evercore ISI - MarketBeat
MarketBeat
Is it possible to buy 89bio Inc(ETNB) shares at a good price now? – US Post News - US Post News
US Post News
89bio shares target cut to $33 on higher expenses - Investing.com
Investing.com
89bio, Inc. (NASDAQ:ETNB) insider upped their holding by 23% earlier this year - Yahoo New Zealand News
Yahoo New Zealand News
Gaining Ground: 89bio Inc (ETNB) Closes Lower at 8.70, Down -0.11 – DWinneX - The Dwinnex
The Dwinnex
A new trading data show 89bio Inc (ETNB) is showing positive returns. – Sete News - SETE News
SETE News
89bio (NASDAQ:ETNB) Price Target Cut to $29.00 - Defense World
Defense World
BofA Securities's latest rating for ETNB stock – Knox Daily - Knox Daily
Knox Daily
89bio shares target cut, maintains buy rating By Investing.com - Investing.com
Investing.com
89bio (NASDAQ:ETNB) Price Target Lowered to $29.00 at HC Wainwright - MarketBeat
MarketBeat
89bio (NASDAQ:ETNB) Issues Earnings Results - MarketBeat
MarketBeat
(ETNB) Trading Signals - Stock Traders Daily
Stock Traders Daily
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - WICZ
WICZ
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
RBC Capital cuts 89bio shares target on model adjustments - Investing.com India
Investing.com India
RBC Capital cuts 89bio shares target on model adjustments - Investing.com
Investing.com
RBC Capital cuts 89bio shares target on model adjustments - Investing.com UK
Investing.com UK
89bio (NASDAQ:ETNB) Price Target Lowered to $29.00 at HC Wainwright - MarketBeat
MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Purchases 7692 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Defense World
Views of Wall Street's Leading Experts on 89bio Inc – Sete News - SETE News
SETE News
New Strong Sell Stocks for January 21st - Yahoo Movies UK
Yahoo Movies UK
Latest Insider moments: PALEKAR ROHAN, 89bio Inc [ETNB] Chief Executive Officer sold 52718 shares – Knox Daily - Knox Daily
Knox Daily
All You Need to Know About 89BIO (ETNB) Rating Upgrade to Buy - Zacks Investment Research
Zacks Investment Research
All You Need to Know About 89BIO (ETNB) Rating Upgrade to Buy - Yahoo Finance UK
Yahoo Finance UK
89bio, Inc. (NASDAQ:ETNB) insider upped their holding by 23% earlier this year - Yahoo New Zealand News
Yahoo New Zealand News
89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASH - ForexTV.com
ForexTV.com
(ETNB) On The My Stocks Page - Stock Traders Daily
Stock Traders Daily
An Analysis of 89bio Inc (ETNB)'s Potential Price Growth – Knox Daily - Knox Daily
Knox Daily
89bio, Inc. (NASDAQ:ETNB) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Defense World
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
GlobeNewswire Inc.
89bio adds biotech veteran Martin Babler to board - Investing.com
Investing.com
PRIME Scheme: EMA Says Yes To Hookipa, Bluejay & 89bio But No To Six Others - Pink Sheet
Pink Sheet
89bio signs deal for construction of a production facility in China (NASDAQ:ETNB) - Seeking Alpha
Seeking Alpha
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
89bio CEO Rohan Palekar trades over $620k in company stock - Investing.com
Investing.com
89bio Receives EMA PRIME Status for Pegozafermin in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Fibrosis and Compensated Cirrhosis
GlobeNewswire Inc.
89bio wins EMA priority status for MASH candidate pegozafermin - Pharmaceutical Technology
Pharmaceutical Technology
Kapitalisierung:
|
Volumen (24h):